Venrock

Originally established as the venture capital arm of the Rockefeller family in 1969, Venrock partners with entrepreneurs to build some of the world's most disruptive, successful companies. With a primary focus on technology and healthcare, portfolio companies have included 10X Genomics, Apple Computer, AveXis, Check Point Software, CloudFlare, Dollar Shave Club, Gilead Sciences, Idec Pharma, Illumina, Intel, Millennium Pharma, and Nest. The firm operates two programs: a traditional early-stage venture practice spanning healthcare and technology, and Venrock Healthcare Capital Partners, a later-stage healthcare program applying a long-term, venture-style approach to small-cap public companies and late-stage private healthcare investments. It is headquartered in Palo Alto, with additional offices in New York and Cambridge, Massachusetts. Venrock invests across enterprise software, digital health, biotech, AI, and cybersecurity, with 439+ portfolio companies, 17 unicorns, 73 IPOs, and 192 acquisitions to date, including athenahealth and DoubleClick. Its recent funds have typically ranged from $400M–$500M, with total assets under management reaching into the billions. Venrock typically writes checks between $2M and $20M, primarily leading seed through Series B rounds. Its investment approach centers on long-term, patient partnership with entrepreneurs tackling large, difficult problems, drawing on team stability and decade-plus partner tenures to sustain deep relationships with founders and portfolio companies over time.